In December 2025, the pharmaverse/pharmaversesdtm repository focused on code health and maintainability, delivering targeted cleanup work that simplifies data handling and reduces dependency surface. This foundation strengthens reliability across environments and accelerates future feature work.

Month: 2025-11 Overview: Focused on delivering updated Alzheimer's Disease Neuro SDTM datasets for neuro studies, while ensuring data integrity and clear documentation. The work emphasizes data quality, maintainability, and traceability to support robust downstream analytics and regulatory readiness. Key outcomes: - Delivered feature: Alzheimer's Disease Neuro SDTM datasets updates and BRTHDTC integration for AG, DM, NV, SUPPNV domains. Achieved improved data handling, consistent labeling, and alignment with new BRTHDTC field documentation and related data structure changes. - Implemented initial dataset updates with comprehensive formatting and data refreshes across ag_neuro, nv_neuro, dm_neuro, and suppnv_neuro; updated NEWS.md to reflect the issue linkage and feature context; adjusted dm_neuro.Rd documentation to reflect BRTHDTC placement. - Addressed data integrity risk by reverting unintended changes: Reverted changes to ag_neuro, dm_neuro, and nv_neuro to restore integrity and stability after the initial updates. - Documentation and governance: Updated Rd files and NEWS to improve maintainability and traceability; maintained clear commit history across changes. Impact: Improved analytics readiness and data quality for Alzheimer's neuro SDTM datasets, reducing risk in downstream analyses and reporting, with enhanced traceability for future updates. Technologies/skills demonstrated: SDTM domain updates, BRTHDTC data integration, R documentation editing (Rd), dataset formatting and labeling, Git version control and rollback procedures, issue tracking linkage in NEWS, data governance through disciplined commit messaging.

September 2025: Delivered Admiralneuro toolkit for Alzheimer's PET imaging within pharmaverse/blog, enabling Centiloid-based standardization and reproducible analytics. The work emphasizes business value through improved research productivity, standardized metrics, and ready-to-run templates for rapid deployment across studies.

July 2025 monthly summary for pharmaverse/admiralneuro focused on advancing NV Neuro Dataset quality and consistency. Implemented tracer consistency across patient visits, updated date handling, and refactored data creation to support multiple tracer types and vendors, including logic to differentiate Tau tracer visit dates. This work resolves key data integrity concerns and enhances realism in neuroimaging analyses. Includes closing related issues and robust commit-level traceability.